Sol-gel technologies to present at upcoming h.c. wainwright global investment conference

Ness ziona, israel, sept. 09, 2021 (globe newswire) -- sol-gel technologies, ltd. (nasdaq: slgl), a dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced that the company will participate in h.c. wainwright's 23rd global investment conference.
SLGL Ratings Summary
SLGL Quant Ranking